CIK: 1902368 - Address: C/O Travere Therapeutics, Inc., 3611 Valley Centre Drive, Suite 300, San Diego, CA 92130
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
7/2/25 17:28
7/1/25
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsInrig JulaCAOChief MeS-1214.650-1-189D
2/12/25 21:22
2/10/25
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsInrig JulaCAOChief MeM.d00.00081090D
2/12/25 21:22
2/12/25
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsInrig JulaCAOChief MeS.d-6023.530-3-390D
2/4/25 20:30
2/3/25
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsInrig JulaCAOChief MeS.dm-10620.120-5-684D
1/6/25 19:21
1/3/25
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsInrig JulaCAOChief MeS.m-4819.040-3-459D
9/10/24 16:05
9/10/24
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsInrig JulaCAOChief MeS-912.980-1-162D
9/9/24 21:20
9/9/24
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsInrig JulaCAOChief MeS-2511.520-2-363D
2/2/24 16:05
2/1/24
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsInrig JulaCAOChief MeS.d-198.530-2-458D
1/5/24 16:11
1/3/24
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsInrig JulaCAOChief MeS.m-249.430-3-735D
1/6/23 16:05
1/4/23
TVTXTravere Therapeutics, Inc.CAHealthDrugPharmaceutical PreparationsInrig JulaCAOChief MeS.m-5220.750-2-1218D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact